Picture of Spectral Medical logo

EDT Spectral Medical Share Price

0.000.00%
ca flag iconLast trade - 00:00
HealthcareAdventurousSmall CapMomentum Trap

Momentum

Relative Strength (%)
1m-19.75%
3m+17.66%
6m+10.85%
1yr+35.17%
Volume Change (%)
10d/3m-20.98%
Price vs... (%)
52w High-28.36%
50d MA-9.4%
200d MA+21.44%

Growth & Value

Shareholder Activity

TypeBuy / Hold / Sell
Institutions
Directors
Community

Guru Screens

Quality

NameIndustryMarket
Return on Capital-141.24%
Return on Equityn/a
Operating Margin-444.31%

Health Trend(F-Score)

12345678910

Bankruptcy Score(Z-Score)

Distress
Cautious
Safe

Earnings Manipulation Risk(M-Score)

Other Ratios

Leverage (ttm)Total- Intang+ Pension
Gross Gearing
Net Gearing
Cash / Assets

Recent History

Latest interim period vs. prior periodIndustryMarket
Sales Growth
EPS Growth
3yr Compound Annual Growth RateIndustryMarket
Sales CAGR
EPS CAGR
DPS CAGR

Graphical History

Revenue
Blurred out image of Revenue chart
Net Income
Blurred out image of Net Income chart
Normalised EPS
Blurred out image of Normalised EPS chart
PE Ratio Range
Blurred out image of PE Ratio Range chart
Dividend Yield Range
Blurred out image of Dividend Yield Range chart

Analyst Forecasts

Price target
( price)
31st Dec 202331st Dec 2024
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change

Analyst Consensus

Strong SellSellHoldBuyStrong Buy

EPS 2023 / 2024

Blurred out image of Spectral Medical EPS forecast chart

Profile Summary

Spectral Medical Inc. is a Canada-based late-stage theragnostic company advancing therapeutic options for sepsis and septic shock. The Company develops and commercializes a treatment for septic shock utilizing its Endotoxin Activity Assay (EAA) diagnostic and the Toraymyxin therapeutic (PMX). PMX is a therapeutic hemoperfusion device that removes endotoxin, which can cause sepsis, from the bloodstream and is guided by the Company’s EAA. PMX has been on the market in many countries outside the United States and has been used in more than 340,000 patients to date. It is engaged in the development of biochemical markers for the clinical syndrome known as septic shock. It is also continuing its legacy business of manufacturing and selling certain reagents. It develops, produces and markets recombinant proteins, antibodies and calibrators. These materials are sold for use in research and development, as well as in products manufactured by other diagnostic companies.

Directors

Last Annual
December 31st, 2022
Last Interim
September 30th, 2023
Incorporated
April 1st, 2005
Public Since
July 16th, 1992
No. of Employees
32
Sector
Pharmaceuticals
Industry
Healthcare
Exchange
ca flag iconToronto Stock Exchange
Shares in Issue
278,644,428

EDT Share Price Performance

Upcoming Events for EDT

Q1 2024 Spectral Medical Inc Earnings Release

Spectral Medical Inc Annual Shareholders Meeting

Q2 2024 Spectral Medical Inc Earnings Release

Similar to EDT

Picture of Aurora Cannabis logo

Aurora Cannabis

ca flag iconToronto Stock Exchange

Picture of Auxly Cannabis logo

Auxly Cannabis

ca flag iconToronto Stock Exchange

Picture of Bausch Health Companies logo

Bausch Health Companies

ca flag iconToronto Stock Exchange

Picture of Canopy Growth logo

Canopy Growth

ca flag iconToronto Stock Exchange

Picture of Charlotte's Web Holdings logo

Charlotte's Web Holdings

ca flag iconToronto Stock Exchange

FAQ